SCHEMBL9988583

SCHEMBL9988583

Oc1ccc[c]c1-c1ccccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
HPGD P15428 5/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
HSD17B10 Q99714 3/20 0.39
MAPT P10636 3/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
ALOX15 P16050 2/20 0.39
NFKB1 P19838 2/20 0.39
ALOX12 P18054 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
TSHR P16473 2/20 0.39
CYP2A6 P11509 1/20 0.39
KDM4E B2RXH2 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
LMNA P02545 2/20 0.39
PIK3CA P42336 2/20 0.39
CA12 O43570 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16719835 0.85 TSHR (0.50) ALDH1A1MEN1KMT2ANFKB1TSHR
SCHEMBL2373478 0.84 SMN1; SMN2 (0.46) ALDH1A1HPGDSMN1; SMN2HSD17B10MAPT
SCHEMBL3990580 0.84 CYP2A6 (0.44) ALDH1A1HPGDSMN1; SMN2HSD17B10KMT2A
SCHEMBL8560761 0.82 CYP2A6 (0.43) ALDH1A1HPGDSMN1; SMN2KMT2ATSHR
SCHEMBL16720299 0.80 HSD17B10 (0.44) ALDH1A1HPGDSMN1; SMN2HSD17B10MAPT
SCHEMBL16720053 0.78 TSHR (0.45) ALDH1A1HPGDSMN1; SMN2HSD17B10MAPT
SCHEMBL8375778 0.77 ALOX15 (0.46) ALDH1A1HPGDSMN1; SMN2HSD17B10MAPT
SCHEMBL16720271 0.77 MAPT (0.39) ALDH1A1HPGDSMN1; SMN2HSD17B10MAPT
SCHEMBL7458982 0.77 CYP2A6 (0.59) ALDH1A1HPGDSMN1; SMN2HSD17B10KMT2A
SCHEMBL10506626 0.77 PLA2G7 (0.41) ALDH1A1HPGDSMN1; SMN2KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2397462-A2 Compounds, compositions and methods of treatment for heart failure Cytokinetics, Inc. (US) 2011-12-21 EP claimed
EP-3068758-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE The Wistar Institute Of Anatomy And Biology (US) 2016-09-21 EP disclosed
WO-2015073864-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE THE WISAR INSTITUTE OF ANATOMY AND BIOLOGY (US) 2015-05-21 WO disclosed